» Articles » PMID: 20032198

The Calcium-sensing Receptor Couples to Galpha(s) and Regulates PTHrP and ACTH Secretion in Pituitary Cells

Overview
Journal J Endocrinol
Specialty Endocrinology
Date 2009 Dec 25
PMID 20032198
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The calcium-sensing receptor (CaR or CASR as listed in the MGI Database) is a G protein-coupled receptor that binds and signals in response to extracellular calcium and other polycations. It is highly expressed on parathyroid and kidney cells, where it participates in the regulation of systemic calcium homeostasis. It is also expressed on many other cell types and is involved in a wide array of biological functions such as cell growth and differentiation, ion transport, and hormone secretion. It has been described to couple to several different G proteins including Galpha(i/0), Galpha(q/11), and Galpha(12/13). Recently, it has also been shown to stimulate cAMP production by coupling to Galpha(s) in immortalized or malignant breast cells. The CaR is expressed on cells in the anterior pituitary and had previously been described to stimulate cAMP production in these cells. In this report, we examined signaling from the CaR in murine pituitary corticotroph-derived, AtT-20 cells. We found that CaR activation led to the stimulation of cAMP production, and PTH-related protein (PTHrP or PTHLH as listed in the MGI Database) and ACTH secretion from these cells. Furthermore, manipulation of cAMP levels was able to modulate PTHrP and ACTH secretion independent of changes in extracellular calcium. Finally, we demonstrated that the CaR couples to Galpha(s) in AtT-20 cells. Therefore, in pituitary corticotroph-like cells, as in breast cancer cells, the CaR utilizes Galpha(s) and activates cAMP production to stimulate hormone secretion.

Citing Articles

Promiscuous G-protein activation by the calcium-sensing receptor.

Zuo H, Park J, Frangaj A, Ye J, Lu G, Manning J Nature. 2024; 629(8011):481-488.

PMID: 38632411 PMC: 11844898. DOI: 10.1038/s41586-024-07331-1.


Hyperaminoacidemia induces pancreatic α cell proliferation via synergism between the mTORC1 and CaSR-Gq signaling pathways.

Gong Y, Yang B, Zhang D, Zhang Y, Tang Z, Yang L Nat Commun. 2023; 14(1):235.

PMID: 36646689 PMC: 9842633. DOI: 10.1038/s41467-022-35705-4.


Peripartal treatment with low-dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone.

Sheftel C, Sartori L, Hunt E, Manuel R, Bell A, Domingues R Physiol Rep. 2022; 10(5):e15204.

PMID: 35234346 PMC: 8889862. DOI: 10.14814/phy2.15204.


The bromodomain inhibitor JQ1+ reduces calcium-sensing receptor activity in pituitary cell lines.

Lines K, Gluck A, Thongjuea S, Bountra C, Thakker R, Gorvin C J Mol Endocrinol. 2021; 67(3):83-94.

PMID: 34223822 PMC: 8345903. DOI: 10.1530/JME-21-0030.


Heterogeneity of G protein activation by the calcium-sensing receptor.

Abid H, Inoue A, Gorvin C J Mol Endocrinol. 2021; 67(2):41-53.

PMID: 34077389 PMC: 8240730. DOI: 10.1530/JME-21-0058.


References
1.
Taylor S, Kim C, Vigil D, Haste N, Yang J, Wu J . Dynamics of signaling by PKA. Biochim Biophys Acta. 2005; 1754(1-2):25-37. DOI: 10.1016/j.bbapap.2005.08.024. View

2.
Akino K, Ohtsuru A, Kanda K, Yasuda A, Yamamoto T, Akino Y . Parathyroid hormone-related peptide is a potent tumor angiogenic factor. Endocrinology. 2000; 141(11):4313-6. DOI: 10.1210/endo.141.11.7875. View

3.
RYAN W, Heidrick M . Role of cyclic nucleotides in cancer. Adv Cyclic Nucleotide Res. 1974; 4(0):81-116. View

4.
Hofle G, Gasser R, Buchfelder M, Fahlbusch R, Waldenberger P, Finkenstedt G . Elevated inferior petrosal sinus levels of PTHrP in a patient with Cushing's disease. Clin Endocrinol (Oxf). 2001; 54(4):555-7. DOI: 10.1046/j.1365-2265.2001.01101.x. View

5.
Tfelt-Hansen J, Brown E . The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci. 2005; 42(1):35-70. DOI: 10.1080/10408360590886606. View